Labcorp Extends Receivables Facility to 2029, Boosts Capacity by $125 Million

summarizeSummary

Labcorp extended its receivables purchase agreement to 2029 and increased its accordion facility by $125 million, enhancing long-term liquidity and financial flexibility.

check_boxKey Events

• Receivables Facility Extended

  The scheduled termination date of the receivables purchase agreement was extended from August 23, 2027, to January 26, 2029.

• Accordion Facility Increased

  A committed $125 million accordion facility was added, raising the total facility limit from $700 million to $825 million.

• SOFR Adjustment Removed

  A 0.10% SOFR adjustment was removed from capital accruing yield, potentially reducing financing costs.

• Default Threshold Raised

  The Threshold Amount for certain indebtedness default triggers was increased from $200 million to $250 million.

auto_awesomeAnalysis

Labcorp Holdings Inc. has amended its receivables purchase agreement, extending the scheduled termination date by over two years to January 26, 2029. This extension provides enhanced long-term liquidity and financial stability. Additionally, the company added a committed $125 million accordion facility, increasing the total facility limit from $700 million to $825 million, which significantly expands its available capital. The removal of a 0.10% SOFR adjustment also slightly reduces financing costs. These changes collectively improve Labcorp's financial flexibility and access to capital.